<p>It might sound greedy but I ashamed that I did not control my urge to trade. I’m ashamed that I didn’t make more money. I need to understand more trader psychology.</p>
<p>Yes they are trades but I want the killer trades.</p>
<p>Shame comments are not meant to be taken seriously.</p>
<p>That’s good. My friend would be dead due to all the losing trades he has had. More losers than me and I have had a ton. I wasn’t exaggerating when I said I lost over 100,000 times. Not that I enjoy the losing trades. I don’t. They are part of the game.</p>
<p>If aapl traded a little differently, the condor trade would have been a loser. </p>
<p>Trading can provide insights into a person’s psychology which is one thing I always liked about trading. </p>
<p>I didn’t trade VNET very well either. I shorted at 19.25 and covered at 18.07. I like quick money but this stock is one I could have made a lot more money on. I am not sure I understand what moved the stock up so much. Somebody forced it up and that mislead me. It may be that the company has a buyback and it exercised that by buying shares yesterday or it could be a lot of short covering or something else. Either way, I couldn’t figure it out. When the stock went back up to 22 or 23 I should have been all in on the short and not wait until 19.25. </p>
<p>Morgan Stanely reiterated its positive rating on VNET. Either they are right or they have some serious risk takers.</p>
<p>I saw so many law firms started investigations on the company. I noticed when these analysts want to get rid of these stocks they have positive rating until the analyst sell the stocks. Very tricky.</p>
<p>Anybody think they’re getting any alibaba stock?</p>
<p>They’re offering it on the fidelity brokerage site, so I would think some would be available. I’m not putting in an indication. </p>
<p>I don’t see it. Where on their website is it?</p>
<p>Here’s the link on Fidelity:
<a href=“Fidelity | Initial Public Offerings(IPOs)”>https://eresearch.fidelity.com/eresearch/ipo/ipocalendar.jhtml</a></p>
<p>And here is what you would need to be eligible to participate:
<a href=“Fidelity | Initial Public Offerings(IPOs)”>Fidelity | Initial Public Offerings(IPOs);
<p>(Read the section titled “Eligibility”)</p>
<p>Basically you’ve got to have a lot of money with fidelity-- they seem to have restrictions that apply to the secondary offerings as well (which I find odd).</p>
<p>I think the best way to get on the Alibaba bandwagon may be to ride Yahoo’s coattails. I think YHOO’s fortunes are going to rise or fall with Alibaba. </p>
<p>Interesting, calmom. A couple of bios are on that list. </p>
<p>Do you like those bios BunsenBurner ?</p>
<p>You can get list of all upcoming IPO’s here:
<a href=“http://www.nasdaq.com/markets/ipos/”>http://www.nasdaq.com/markets/ipos/</a></p>
<p>(It’s a Nasdaq web page but it includes NYSE)</p>
<p>Have no clue, really, dstark. Gotta do some research on them, see what CrunchBase and others have on them! Bio IPOs are very tricky, IMO. Very Biotech index-dependent.</p>
<p>I think bio companies can be all over the map in terms of performance. I had shares of GILD that I picked up recently which was doing well, but then there was one odd day where the stock plunged in the morning and came back up and I got stopped out. But I’ve done ok in the past with GILD options as well. But over all the bios tend to be pretty shaky with lots of ups and downs. </p>
<p>Ok. I was just wondering about those latest companies that are going public.</p>
<p>CrunchBase looks very interesting.</p>
<p>Start ups have not been my thing. I am too far down the food chain.</p>
<p>Some startups can become big ones… Most fizzle out.</p>
<p>The thing with biotechs is that they tend to file for IPOs when the overall biotech sector is doing fine (or they think it will be doing fine). The number of bios in the IPO pipeline tells me that the sector, at least in the nearest future, is projected to do OK. I could be completely wrong, so do not take this as investment advice, LOL.</p>
<p>GILD has a very interesting history. It used to be an antisense co in the early to mid 90’s, amassed a huge portfolio of IP covering modified nucleic acid tech, then sold all of its antisense IP to ISIS Pharma and went after small molecules while doing a number of acquisitions along the way, including a local co. Smart strategy that pays off. It also did not hurt to have some connections within the White House:)</p>
<p>“Some startups can become big ones… Most fizzle out.”</p>
<p>Yes they do…and if I see them in an early stage…others more connected and smarter said no. :)</p>
<p>I probably wont invest in start ups anymore. </p>
<p>I agree with your second paragraph too to an extent. At some point, when an industry is on fire, too many ipos of low quality in that sector become public and the sector drops for awhile. </p>
<p>I did not know about gild’s white house connections. Interesting history.</p>
<p>Dont worry BunsenBurner. You are not held to what you say. :)</p>
<p>Here’s one I never saw coming. LE (Land’s End) – went public in April --spiked up 10 points in the last 2 days – 34 to 44. </p>
<p>^Kramer was touting Land’s End the other day. In the past, I noticed stocks mentioned in Mad Money rise a lot briefly.</p>
<p>For Apple options traders,</p>
<p><a href=“Traders Gobble Up Apple Options After Cook's Big Reveal - WSJ”>Traders Gobble Up Apple Options After Cook's Big Reveal - WSJ;